Oligonucleotide Therapeutics and Delivery Conference

Sciinov Group is proud to announce the Oligonucleotide Therapeutics and Delivery Conference on August 18-19, 2025, in San Francisco, CA, USA. This year's OTDC 2025 annual Oligonucleotide Therapeutics and Delivery conference will showcase recent advances in oligonucleotide development, regulatory requirements and CMC considerations, strategies to enhance oligonucleotide discovery, and targeting and optimizing delivery techniques for oligonucleotide-based therapies in the hope of continuing to drive forward the field of oligonucleotide drug development. Join us on August 18-19, 2025, in San Francisco, CA, USA.

Industry and academic experts deliver detailed case studies on antisense, RNA, GalNAc, aptamers, conjugates and other new modalities, paving the way for the next generation of targeted oligonucleotide therapeutics.

Benefits of Attending:
 - Listen to case studies presenting on pre-clinical and clinical research in areas such as oncology and what can be learned for future clinical trials
 - Deepen your understanding of oligonucleotide therapeutic delivery and explore the latest innovations in extrahepatic oligonucleotide delivery and target specificity
 - Understand the regulatory and CMC environment surrounding oligonucleotide therapeutic development
 - Explore developments in oligonucleotide chemistries and examine developments in novel applications of antisense oligonucleotides and siRNA
 - Engage in the latest innovations in oligonucleotide therapeutics such as utilising AI machine learning to drive the discovery of novel therapeutics

Who should attend:
 - Executives, Directors, VPs, Heads, Principals, Managers of:
 - RNA Biology/Discovery
 - Novel Therapeutic Modalities
 - Innovation Technologies
 - Formulation and Drug Delivery
 - Clinical Research and Development
 - Cell Biology